Bridgewater Advisors Inc. lowered its position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 3.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,810 shares of the company’s stock after selling 861 shares during the quarter. Bridgewater Advisors Inc.’s holdings in Cardinal Health were worth $2,953,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Paragon Capital Management Inc. lifted its position in shares of Cardinal Health by 0.7% in the 2nd quarter. Paragon Capital Management Inc. now owns 14,758 shares of the company’s stock worth $1,451,000 after buying an additional 99 shares during the last quarter. Huntington National Bank raised its stake in Cardinal Health by 0.9% during the third quarter. Huntington National Bank now owns 10,792 shares of the company’s stock worth $1,193,000 after acquiring an additional 100 shares during the period. Blair William & Co. IL lifted its holdings in Cardinal Health by 0.9% in the second quarter. Blair William & Co. IL now owns 11,442 shares of the company’s stock worth $1,125,000 after acquiring an additional 103 shares during the last quarter. Frazier Financial Advisors LLC boosted its stake in Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after acquiring an additional 104 shares during the period. Finally, UMB Bank n.a. grew its holdings in shares of Cardinal Health by 4.9% during the third quarter. UMB Bank n.a. now owns 2,249 shares of the company’s stock valued at $249,000 after purchasing an additional 106 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on the company. Wells Fargo & Company raised Cardinal Health from an “underweight” rating to an “equal weight” rating and raised their price target for the stock from $101.00 to $127.00 in a report on Friday, December 13th. UBS Group boosted their price target on shares of Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a report on Monday, November 4th. TD Cowen raised shares of Cardinal Health from a “hold” rating to a “buy” rating and increased their price objective for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. Citigroup boosted their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. Finally, StockNews.com lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $133.29.
Cardinal Health Price Performance
Shares of CAH opened at $126.27 on Monday. The stock has a market capitalization of $30.56 billion, a P/E ratio of 24.57, a P/E/G ratio of 1.48 and a beta of 0.63. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $127.27. The firm’s 50 day moving average is $120.75 and its 200-day moving average is $112.03.
Cardinal Health (NYSE:CAH – Get Free Report) last issued its earnings results on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The business had revenue of $52.28 billion for the quarter, compared to analysts’ expectations of $50.90 billion. During the same period in the previous year, the firm posted $1.73 EPS. The company’s quarterly revenue was down 4.3% on a year-over-year basis. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 7.82 EPS for the current fiscal year.
Cardinal Health Cuts Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd were given a $0.5056 dividend. This represents a $2.02 annualized dividend and a dividend yield of 1.60%. The ex-dividend date was Thursday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 39.30%.
Cardinal Health Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading
- Five stocks we like better than Cardinal Health
- Most Volatile Stocks, What Investors Need to Know
- Small-Cap Titans: 3 Russell 2000 Winners for 2025
- What is the Australian Securities Exchange (ASX)
- Unusual Call Option Volume in US Steel: Potential Upside Ahead?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Energy Storage Stocks Charging the Renewable Energy Sector
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.